A team from the University of Coimbra has found that higher coffee consumption may lessen how severely non-alcoholic fatty liver disease (NAFLD) manifests in people who are overweight and living with type 2 diabetes. This finding was reported in Nutrients and adds a new perspective to how common dietary habits can influence liver health in metabolic disease.
NAFLD describes a spectrum of liver conditions tied to excess fat in the liver, not caused by alcohol. In some individuals, this fat buildup evolves into fibrosis, potential liver scarring, cirrhosis, and even liver cancer if not monitored. NAFLD is frequently linked to lifestyle factors such as physical inactivity and diets rich in calories and fats, which makes it a public health concern across North America where rates of obesity and type 2 diabetes climb.
In the study, investigators enrolled 156 adults with an average body mass index close to the overweight range. Among them, 98 had type 2 diabetes. Urine samples were collected over a full day to capture natural fluctuations in coffee-derived compounds, and researchers assessed how these substances appeared in the body. The goal was to see whether higher exposure to coffee components correlated with liver health markers.
The results reinforced prior observations that caffeine intake can be linked to reduced liver fibrosis in NAFLD and other chronic liver conditions. Participants with higher caffeine levels tended to show a lower likelihood of developing significant liver fibrosis. Moreover, elevated urinary signals of other coffee constituents were associated with a reduced burden of fatty liver and better liver fat management. This pattern suggests that components beyond caffeine, such as polyphenols, may contribute to liver health in a meaningful way.
Scientists propose that coffee polyphenols help lower oxidative stress in liver tissues. When oxidative stress is reduced, liver cells may metabolize glucose more efficiently, which benefits both healthy and overweight individuals. The protective effects on the liver could also translate into a diminished risk of progression to fibrosis. In practical terms, these mechanisms might help temper the severity of type 2 diabetes as well, since liver health and glucose regulation are tightly connected in metabolic disease. In the context of Canadian and American populations where NAFLD prevalence intersects with rising diabetes rates, incorporating moderate coffee consumption as part of a balanced diet could be a consideration for clinicians and patients alike, though it should be tailored to individual health needs and monitored by healthcare providers based on overall risk factors and kidney or heart health considerations. Experts emphasize that coffee should complement, not replace, established lifestyle changes such as regular physical activity and a nutritious diet. The study’s findings add to a growing body of evidence supporting a nuanced view of coffee as a potential aid in managing fatty liver disease and metabolic health in diverse populations, including those in North America. This line of inquiry continues to unfold, with ongoing research needed to confirm long-term outcomes and identify which coffee compounds offer the most benefit for liver and metabolic health. As more data emerge, clinicians may refine recommendations about caffeine intake and coffee-derived polyphenols in the context of NAFLD and type 2 diabetes care. Attribution to Nutrients indicates that these insights reflect current scientific understanding and should be interpreted within a broader clinical framework.
Related posts:
Dietary fat quality and NAFLD risk: fatty fish vs lean fish The goalscorers of Lionel Scaloni’s cycle in the Argentina national team NAFLD, Fibrosis, and Reduced Lung Capacity: New Insights Understanding NAFLD: Risk Factors, Measurements, and Early Detection Klebsiella pneumoniae and Fatty Liver Disease: Gut Microbes as a Factor in NAFLD NAFLD and the Urea Cycle: New Clues for Treatment Coffee, Caffeine, and Mindset: How Belief Shapes Wakefulness and Brain Activity Caffeine, Genetics, and Metabolic Health: What the Research Shows Uncovering gp130’s Role in Protecting the Liver from Obesity-Related Damage Loneliness and NAFLD Risk: A North American Context Coffee without sugar: health, taste, and daily impact Fatty Liver Disease: Key Causes, Risks, and Management